Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens

Pathologie Biologie

Volumn 61, Issue 5, 2013, Pages 209-216

  El Fertas Aissani, R ^a   Messai, Y ^a   Alouache, S ^a   Bakour, R ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

Author keywords

Clinical isolates; Klebsiella pneumoniae; Virulence

Indexed keywords

AEROBACTIN; ANTIBIOTIC AGENT; CYTOTOXIC NECROTIZING FACTOR 1; EMOXIPIN; ENTEROCHELIN; IRON REGULATORY PROTEIN 1; MANNOSE; YERSINIABACTIN;

AEROBACTIN GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOOD VISCOSITY; CATECHOL RECEPTOR GENE; CNF 1 GENE; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROBACTIN GENE; FIMH 1 GENE; HEMAGGLUTINATION; HLYA GENE; IN VIVO STUDY; IRP 1 GENE; IRP 2 GENE; KLEBSIELLA PNEUMONIAE INFECTION; KPN GENE; LD 50; MAGA GENE; MALE; MOUSE; MRKD GENE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPIC VARIATION; POLYMERASE CHAIN REACTION; RMPA GENE; SENSITIVITY ANALYSIS; TRAT GENE; YBTS GENE; YCFM GENE; YERSINIABACTIN GENE;

CLINICAL ISOLATES; KLEBSIELLA PNEUMONIAE; SOUCHES CLINIQUES; VIRULENCE;

ADHESINS, BACTERIAL; ALGERIA; ANIMALS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; KLEBSIELLA PNEUMONIAE; LETHAL DOSE 50; MICE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SIDEROPHORES; VIRULENCE FACTORS;

EID: 84886778445     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2012.10.004     Document Type: Article

References (55)

1. Podschun R., Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998, 11:589-603.
2. Barreto S., Zambrano M., Araque M. Phenotypic variations of susceptibility in Klebsiella pneumoniae strains of nosocomial origin and their association with biofilm formation. Invest Clin 2009, 50:221-229.
3. Schroll C., Barken K.B., Krogfelt K.A., Struve C. Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol 2010, 10:179-188.
4. Wiskur B.J., Hunt J.J., Callegan M.C. Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci 2008, 49:4931-4938.
5. Yu V.L., Hansen D.S., Ko W.C., Sagnimeni A., Klugman K.P., von Gottberg V., et al. Virulence characteristics of Klebsiella and clinical manifestations of K.pneumoniae bloodstream infections. Emerg Infect Dis 2007, 13:986-993.
6. Tsai F.C., Huang Y.T., Chang L.Y., Wang J.T. Phylogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis 2008, 14:1592-1600.
7. Yeh K.M., Kurup A., Siu L.K., Koh Y.L., Fung C.P., Lin J.C., et al. Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol 2007, 45:466-471.
8. Lee S.Y., Kotapati S., Kuti J.L., Nightingale C.H., Nicolau D.P. Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 2006, 27:1226-1232.
9. Decré D., Burghoffer B., Gautier V., Petit J.C., Arlet G. Outbreak of multiresistant Klebsiella oxytoca involving strains with extended-spectrum beta-lactamase. J Antimicrob Chemother 2004, 54:881-888.
10. Mishra M., Thakar Y.S., Pathak A.A. Haemagglutination, haemolysin production and serum resistance of Proteus and related species isolated from clinical sources. Indian J Med Microbiol 2001, 19:5-11.
11. Fierer J., Finley F., Braude A.I. A plaque assay on agar for detection of Gram-negative bacilli sensitive to complement. J Immunol 1972, 109:1156-1158.
12. Schwyn B., Neilands J.B. Universal chemical assay for the detection and determination of siderophores. Anal Biochem 1987, 160:47-56.
13. Hantke K. Dihydroxybenzoylserine-a siderophore for Escherichia coli. FEMS Microbiol Lett 1990, 55:5-8.
14. Podschun R., Sievers D., Foscher A., Ullmann U. Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J Infect Dis 1993, 168:1415-1421.
15. Koczura R., Kaznowski A. Occurrence of the Yersinia high-pathogenicity island and iron uptake systems in clinical isolates of Klebsiella pneumoniae. Microb Pathog 2003, 35:197-202.
16. Kokosharov T., Phetisova K. Hemolysins and aerobactin in Salmonella Gallinarum strains isolated from poultry. Rev Med Vet 2002, 153:411-414.
17. Maldonado N.C., Silva de Ruiz C., Cecilia M., Nader-Macias M.E. A simple technique to detect Klebsiella biofilm-forming-strains. Inhibitory potential of Lactobacillus fermentum CRL 1058 whole cells and products. In: Méndez-Vilas A (editor). Communicating current research and educational topics and trends in applied microbiology. Microbiology 2007, 1:52-59.
18. Mamlouk K., Boutiba-Ben Boubaker I., Gautier V., Vimont S., Picard B., Ben Redjeb S., et al. Emergence and outbreaks of CTX-M beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol 2006, 44:4049-4056.
19. Sahly H., Navon-Venezia S., Roesler L., Hay A., Carmeli Y., Podschun R., et al. Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother 2008, 52:3029-3034.
20. Schubert S., Cuenca S., Fischer D., Heesemann J. High-pathogenicity island of Yersinia pestis in Enterobacteriaceae isolated from blood cultures and urine samples: prevalence and functional expression. J Infect Dis 2000, 182:1268-1271.
21. Turton J.F., Baklan V., Siu V., Kaufmann V., Pitt V. Evaluation of a multiplex PCR for detection of serotypes K1, K2 and K5 in Klebsiella sp. and comparison of isolates within these serotypes. FEMS Microbiol Lett 2008, 284:247-252.
22. Bach S., de Almeida A., Carniel E. The Yersinia high-pathogenicity island is present in different members of the family Enterobacteriaceae. FEMS Microbiol Lett 2000, 183:289-294.
23. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938, 27:493-497.
24. Struve C., Bojer M., Krogfelt K.A. Identification of a conserved chromosomal region encoding Klebsiella pneumoniae Type 1 and Type 3 fimbriae and assessment of the role of fimbriae in pathogenicity. Infect Immun 2009, 77:5016-5024.
25. Schembri M., Blom J., Krogfelt K., Klemm P. Capsule and fimbriae interaction in Klebsiella pneumoniae. Infect Immun 2005, 73:4626-4633.
26. Roos V., Ulett G.C., Schembri M.A., Klemm P. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E.coli strains in human urine. Infect Immun 2006, 74:615-624.
27. May T., Okabe S. Enterobactin is required for biofilm development in reduced-genome Escherichia coli. Environ Microbiol 2011, 13:3149-3162.
28. Lai Y.C., Peng H.L., Chang H.Y. Identification of genes induced in vivo during Klebsiella pneumoniae CG43 infection. Infect Immun 2001, 69:7140-7145.
29. Nassif X., Sansonetti P.J. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infect Immun 1986, 54:603-608.
30. Podschun R., Fischer A., Ullmann U. Siderophore production of Klebsiella species isolated from different sources. Zentralbl Bakteriol 1992, 276:481-486.
31. Podschun R., Fischer A., Ullmann U. Expression of putative virulence factors by clinical isolates of Klebsiella planticola. J Med Microbiol 2000, 49:115-119.
32. Vernet V., Madoulet V., Chippaux V., Philippon A. Incidence of two virulence factors (aerobactin and mucoid phenotype) among 190 clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamase. FEMS Microbiol Lett 1992, 75:1-5.
33. Bachman M.A., Oyler J.E., Burns S.H., Caza M., Lépine F., Dozois C.M., et al. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun 2011, 79:3309-3316.
34. Lawlor M.S., O'connor C., Miller V.L. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 2007, 75:1463-1472.
35. Hancock V., Ferrieres L., Klemm P. The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli in human urine. Microbiology 2008, 154:167-175.
36. Paauw A., Leverstein-van Hall M.A., van Kessel K.P., Verhoef J., Fluit A.C. Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells. PLoS One 2009, 4:e8240.
37. Carniel E. The Yersinia high-pathogenicity island. Int Microbiol 1999, 2:161-167.
38. Chen Y.T., Chang H.Y., Lai Y.C., Pan C.C., Tsai S.F., Peng H.L. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene 2004, 337:189-198.
39. Bachman M.A., Miller V.L., Weiser J.N. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog 2009, 5:e1000622.
40. Müller S.I., Valdebenito M., Hantke K. Salmochelin, the long-overlooked catecholate siderophore of Salmonella. Biometals 2009, 22:691-695.
41. Cortés G., Borrell N., de Astorza B., Gómez C., Sauleda J., Albertí S. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 2002, 70:2583-2590.
42. Benge G.R. Bactericidal activity of human serum against strains of Klebsiella from different sources. J Med Microbiol 1988, 27:11-15.
43. Sahly H., Aucken H., Benedí V.J., Forestier C., Fussing V., Hansen D.S., et al. Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2004, 48:3477-3482.
44. Moll A., Manning P.A., Timmis K.N. Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli. Infect Immun 1980, 28:359-367.
45. Montenegro M.A., Bitter-Suermann D., Timmis J.K., Agüero M.E., Cabello F.C., Sanyal S., et al. traT gene sequences, serum resistance and pathogenicity-related factors in clinical isolates of Escherichia coli and other gram-negative bacteria. J Gen Microbiol 1985, 131:1511-1521.
46. Blum G., Falbo V., Caprioli A., Hacker J. Gene clusters encoding the cytotoxic necrotizing factor type 1, Prs-fimbriae and alpha-hemolysin form the pathogenicity island II of the uropathogenic Escherichia coli strain J96. FEMS Microbiol Lett 1995, 126:189-195.
47. Albesa I. Klebsiella pneumoniae haemolysin adsorption to red blood cells. J Appl Bacteriol 1989, 67:263-266.
48. Gundogan N., Citak S., Yalcin E. Virulence properties of extended-spectrum beta-lactamase-producing Klebsiella species in meat samples. J Food Prot 2011, 74:559-564.
49. Zubair M., Malik A., Ahmad J., Rizvi M., Farooqui K.J., Rizvi M.W. Study of biofilm production by Gram-negative organisms isolated from diabetic foot ulcer patients. Biol Med 2011, 3:147-157.
50. Yang D., Zhang Z. Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum β-lactamases. J Hosp Infect 2008, 68:369-371.
51. Boddicker J.D., Anderson R.A., Jagnow J., Clegg S. Signature-tagged mutagenesis of Klebsiella pneumoniae to identify genes that influence biofilm formation on extracellular matrix material. Infect Immun 2006, 74:4590-4597.
52. Niba E.T., Naka Y., Nagase M., Mori H., Kitakawa M. A genome-wide approach to identify the genes involved in biofilm formation in E.coli. DNA Res 2007, 14:237-246.
53. Tarkkanen A.M., Allen B.L., Williams P.H., Kauppi M., Haahtela K., Siitonen A., et al. Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun 1992, 60:1187-1192.
54. Padilla E., Llobet E., Doménech-Sánchez A., Martínez-Martínez L., Bengoechea J.A., Albertí S. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother 2010, 54:177-183.
55. Martínez J.L., Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002, 15:647-679.